Adverse Events Associated With Immunotherapy in the Treatment of Endometrial Cancer

Christian Marth, MD, PhD, reviews the adverse effects of pembrolizumab and lenvatinib in the treatment of endometrial cancer, as well as the patient experience with these treatments.

Related Keywords

Christian Marth , ,Recurrent Endometrial Cancer ,Endometrial Cancer ,Immunotherapy ,Pembrolizumab ,Lenvatinib ,Hypertension ,Colitis ,Personalized Medicine ,